Literature DB >> 24269043

Current overview of pregnancy complications and live-birth outcome of assisted reproductive technology in mainland China.

Xiaokui Yang1, Ying Li1, Changdong Li1, Weiyuan Zhang2.   

Abstract

OBJECTIVE: To survey the proportion of births born after assisted reproductive technology (ART) and compare the obstetric and prenatal complications between ART and spontaneous pregnancy in women in mainland China.
DESIGN: Retrospective analysis.
SETTING: Thirty-nine hospitals. PATIENT(S): A total of 112,403 deliveries from 14 provinces and 39 different hospitals composed our retrospective study. INTERVENTION(S): A multiprovince, hospital-based survey was performed. MAIN OUTCOME MEASURE(S): The prevalence of obstetric complications, mode of delivery, and prenatal outcomes were compared between ART and spontaneous pregnancy. For each group, data included singleton and twin deliveries. RESULT(S): The proportion of infants born as a result of ART in mainland China was about 1.013% in 2011. The incidence of hypertensive disorder in pregnancy (11.0%, odds ratio [OR], 1.27, 95% confidence interval [CI] 1.04-1.60), premature delivery (27.0%, OR, 4.53, 95% CI 3.91-5.25), gestational diabetes mellitus (15.1%, OR 3.05, 95% CI 2.57-3.60), and placenta previa (4.5%, OR 2.18, 95% CI 1.62-2.94) were markedly increased in women who conceived using ART. The cesarean section rate in the ART pregnancy group was 85.3%, which is significantly higher than spontaneous pregnancies (54.0%). Compared with spontaneous pregnancy, ART pregnancy had a significantly increased incidence of low birth weight babies (29.7%) and birth gestational age of less than 37 weeks (30.0%). Infants conceived by ART have increased low 5-minute Apgar and mortality. CONCLUSION(S): This population-based survey demonstrates that the proportion of births from ART in mainland China was about 1.013% in 2011. Multiple gestation is significantly increased in ART pregnancies, relative to spontaneous pregnancies. The increasing incidence and risk of maternal complications in ART pregnancies (e.g., premature delivery, placenta previa, gestational diabetes mellitus) are found in singleton and twin gestations in ART. A higher cesarean section rate, low birth weight infants, and higher infant mortality rate were also observed in ART pregnancies. Our survey provides a comprehensive overview of the prevalence of ART and ART-associated complications in mainland China, and provides insight into attitudes toward ART among the mainland Chinese population.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assisted reproductive technology; live birth; mainland Chinese population; obstetric complications; perinatal outcome

Mesh:

Year:  2013        PMID: 24269043     DOI: 10.1016/j.fertnstert.2013.10.017

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  36 in total

1.  Increased pregnancy complications following frozen-thawed embryo transfer during an artificial cycle.

Authors:  Shuang Jing; Xiao Feng Li; Shuoping Zhang; Fei Gong; Guangxiu Lu; Ge Lin
Journal:  J Assist Reprod Genet       Date:  2019-03-29       Impact factor: 3.412

Review 2.  Developmental origins of type 2 diabetes: a perspective from China.

Authors:  R C W Ma; K Y Tsoi; W H Tam; C K C Wong
Journal:  Eur J Clin Nutr       Date:  2017-04-05       Impact factor: 4.016

3.  Risk of prematurity and infant morbidity and mortality by maternal fertility status and plurality.

Authors:  Barbara Luke; Morton B Brown; Ethan Wantman; David B Seifer; Amy T Sparks; Paul C Lin; Kevin J Doody; Bradley J Van Voorhis; Logan G Spector
Journal:  J Assist Reprod Genet       Date:  2018-10-17       Impact factor: 3.412

4.  Cohort profile: Anhui Maternal-Child Health Study in China.

Authors:  Jiaqian Yin; Yunxia Cao; Chunmei Liang; Xiaoqing Peng; Xiaofeng Xu; Weiju Zhou; Ranjit Khutan; Fang-Biao Tao; Ruoling Chen
Journal:  BMJ Open       Date:  2022-06-28       Impact factor: 3.006

5.  The live birth and neonatal outcomes in the subsequent pregnancy among patients with adverse pregnancy outcomes in first frozen embryo transfer cycles.

Authors:  Jianghui Li; Jiaying Lin; Mingru Yin; Qianqian Zhu; Yanping Kuang
Journal:  Arch Gynecol Obstet       Date:  2020-05-28       Impact factor: 2.344

6.  In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters.

Authors:  Barbara Luke; Morton B Brown; Michael L Eisenberg; Caitriona Callan; Beverley J Botting; Allan Pacey; Alastair G Sutcliffe; Valerie L Baker
Journal:  Am J Obstet Gynecol       Date:  2019-10-17       Impact factor: 8.661

7.  Frequency of placenta previa in previously scarred and non scarred uterus.

Authors:  Tayyaba Majeed; Fatima Waheed; Zahid Mahmood; Kanwal Saba; Hamis Mahmood; Mulazim Hussain Bukhari
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

8.  Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses.

Authors:  Hui Ju Chih; Flavia T S Elias; Laura Gaudet; Maria P Velez
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-28       Impact factor: 3.007

9.  Association of assisted reproductive technology, germline de novo mutations and congenital heart defects in a prospective birth cohort study.

Authors:  Cheng Wang; Hong Lv; Xiufeng Ling; Hong Li; Feiyang Diao; Juncheng Dai; Jiangbo Du; Ting Chen; Qi Xi; Yang Zhao; Kun Zhou; Bo Xu; Xiumei Han; Xiaoyu Liu; Meijuan Peng; Congcong Chen; Shiyao Tao; Lei Huang; Cong Liu; Mingyang Wen; Yangqian Jiang; Tao Jiang; Chuncheng Lu; Wei Wu; Di Wu; Minjian Chen; Yuan Lin; Xuejiang Guo; Ran Huo; Jiayin Liu; Hongxia Ma; Guangfu Jin; Yankai Xia; Jiahao Sha; Hongbing Shen; Zhibin Hu
Journal:  Cell Res       Date:  2021-06-09       Impact factor: 46.297

10.  Assisted reproductive technology and birth defects in a Chinese birth cohort study.

Authors:  Hong Lv; Feiyang Diao; Jiangbo Du; Ting Chen; Qingxia Meng; Xiufeng Ling; Hong Li; Ci Song; Qi Xi; Yangqian Jiang; Yan Xu; Shiyao Tao; Lei Huang; Mingyang Wen; Meijuan Peng; Cong Liu; Qun Lu; Yuanlin He; Yin Yin; Xiaoyu Liu; Bo Xu; Xiumei Han; Kun Zhou; Tao Jiang; Yang Zhao; Hongxia Ma; Guangfu Jin; Yankai Xia; Jiayin Liu; Yuan Lin; Zhibin Hu; Hongbing Shen
Journal:  Lancet Reg Health West Pac       Date:  2021-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.